Dimensional Fund Advisors LP Allakos Inc. Transaction History
Dimensional Fund Advisors LP
- $403 Billion
- Q3 2024
A detailed history of Dimensional Fund Advisors LP transactions in Allakos Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 89,998 shares of ALLK stock, worth $87,298. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,998
Previous 126,642
28.94%
Holding current value
$87,298
Previous $126,000
53.97%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ALLK
# of Institutions
82Shares Held
64.7MCall Options Held
47.1KPut Options Held
1K-
Bvf Inc San Francisco, CA16.6MShares$16.1 Million0.34% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$5.96 Million0.31% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$4.85 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$3.41 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.08MShares$2.99 Million0.13% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $82.2M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...